Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7571-7580

  Chan, James ^a   Ban, Ee Jun ^a   Chun, Keng Hao ^a   Wang, Shunhe ^b   Bäckström, B Thomas ^c   Bernard, Claude C A ^a   Toh, Ban Hock ^a   Alderuccio, Frank ^d  

^a MONASH UNIVERSITY   (Australia)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DNA MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REMISSION; SPLEEN CELL; THYMOCYTE;

EID: 71849087808     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7571     Document Type: Article

References (45)

1. Alderuccio, F., K. Murphy, and B. H. Toh. 2003. Stem cells engineered to express self-antigen to treat autoimmunity. Trends Immunol. 24: 176-180. (Pubitemid 36412104)
2. Chan, J., C. Siatskas, J. Field, B.-H. Toh, and F. Alderuccio. 2006. Mechanisms and applications of stem cell gene therapy in autoimmunity. Drug Discov. Today: Dis. Mech. 3: 219-223. (Pubitemid 44356300)
3. Bagley, J., and J. Iacomini. 2003. Gene therapy progress and prospects: gene therapy in organ transplantation. Gene Ther. 10: 605-611. (Pubitemid 36553605)
4. Armitage, J. O. 1994. Bone marrow transplantation. N. Engl. J. Med. 330: 827-838.
5. Marmont, A. M. 2008. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J. Autoimmun. 30: 145-150.
6. Burt, R. K., A. Testor, R. Craig, B. Cohen, R. Suffit, and W. Barr. 2008. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned? J. Autoimmun. 30: 116-120.
7. Gualandi, F., B. Bruno, M. T. Van Lint, S. Luchetti, A. Uccelli, E. Capello, G. L. Mancardi, A. Bacigalupo, and A. Marmont. 2007. Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. Ann. NY Acad. Sci. 1110: 455-464. (Pubitemid 350043035)
8. van Gelder, M., and D. W. van Bekkum. 1995. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant. 16: 343-351.
9. Lai, A. Y., and M. Kondo. 2007. Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. Proc. Natl. Acad. Sci. USA 104: 6311-6316.
10. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185: 541-550. (Pubitemid 27078372)
11. Goodnow, C. C., J. Sprent, B. F. de St. Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597. (Pubitemid 40825498)
12. Kubach, J., C. Becker, E. Schmitt, K. Steinbrink, E. Huter, A. Tuettenberg, and H. Jonuleit. 2005. Dendritic cells: sentinels of immunity and tolerance. Int. J. Hematol. 81: 197-203. (Pubitemid 41364484)
13. Kyewski, B., and J. Derbinski. 2004. Self-representation in the thymus: an extended view. Nat. Rev. Immunol. 4: 688-698.
14. Sprent, J., and S. R. Webb. 1995. Intrathymic and extrathymic clonal deletion of T cells. Curr. Opin. Immunol. 7: 196-205.
15. Gallegos, A. M., and M. J. Bevan. 2004. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200: 1039-1049.
16. Alderuccio, F., B. H. Toh, S. S. Tan, P. A. Gleeson, and I. R. van Driel. 1993. An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J. Exp. Med. 178: 419-426. (Pubitemid 23218190)
17. French, M. B., J. Allison, D. S. Cram, H. E. Thomas, M. Dempsey-Collier, A. Silva, H. M. Georgiou, T. W. Kay, L. C. Harrison, and A. M. Lew. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46: 34-39. (Pubitemid 27009946)
18. Saiz, A., Y. Blanco, J. Berenguer, M. Gomez, E. Carreras, T. Arbizu, and F. Graus. 2008. Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis (In Spanish). Neurologia 23: 405-407.
19. Steptoe, R. J., J. M. Ritchie, and L. C. Harrison. 2003. Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J. Clin. Invest. 111: 1357-1363.
20. Ally, B. A., T. S. Hawley, K. J. McKall-Faienza, T. M. Kundig, S. U. Oehen, H. Pircher, R. G. Hawley, and P. S. Ohashi. 1995. Prevention of autoimmune disease by retroviral-mediated gene therapy. J. Immunol. 155: 5404-5408.
21. Bagley, J., C. Tian, D. H. Sachs, and J. Iacomini. 2002. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood 99: 4394-4399. (Pubitemid 34627206)
22. Chan, J., W. Clements, J. Field, Z. Nasa, P. Lock, F. Yap, B. H. Toh, and F. Alderuccio. 2006. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J. Gene Med. 8: 1281-1290. (Pubitemid 44782507)
23. Sykes, M., D. H. Sachs, A. W. Nienhuis, D. A. Pearson, A. D. Moulton, and D. M. Bodine. 1993. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 55: 197-202. (Pubitemid 23033971)
24. Xu, B., P. Haviernik, L. A. Wolfraim, K. D. Bunting, and D. W. Scott. 2006. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol. Ther. 13: 42-48. (Pubitemid 41763481)
25. Zambidis, E. T., A. Kurup, and D. W. Scott. 1997. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol. Med. 3: 212-224.
26. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081. (Pubitemid 36570063)
27. Petersen, T. R., S. Gulland, E. Bettelli, V. Kuchroo, E. Palmer, and B. T. Backstrom. 2004. A chimeric T cell receptor with super-signaling properties. Int. Immunol. 16: 889-894.
28. Biondo, M., J. Field, B. H. Toh, and F. Alderuccio. 2006. Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. J. Pathol. 209: 384-391. (Pubitemid 43997748)
29. Karnezis, T., W. Mandemakers, J. L. McQualter, B. Zheng, P. P. Ho, K. A. Jordan, B. M. Murray, B. Barres, M. Tessier-Lavigne, and C. C. Bernard. 2004. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7: 736-744. (Pubitemid 38859058)
30. Slavin, A., C. Ewing, J. Liu, M. Ichikawa, J. Slavin, and C. C. Bernard. 1998. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 28: 109-120. (Pubitemid 28499584)
31. McQualter, J. L., R. Darwiche, C. Ewing, M. Onuki, T. W. Kay, J. A. Hamilton, H. H. Reid, and C. C. Bernard. 2001. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194: 873-882.
32. Fassas, A., J. R. Passweg, A. Anagnostopoulos, A. Kazis, T. Kozak, E. Havrdova, E. Carreras, F. Graus, A. Kashyap, H. Openshaw, et al. 2002. Hematopoietic stem cell transplantation for multiple sclerosis: a retrospective multicenter study. J. Neurol. 249: 1088-1097. (Pubitemid 35002235)
33. Fassas, A., A. Anagnostopoulos, A. Kazis, K. Kapinas, I. Sakellari, V. Kimiskidis, C. Smias, N. Eleftheriadis, and V. Tsimourtou. 2000. Autologous stem cell transplantation in progressive multiple sclerosis: an interim analysis of efficacy. J. Clin. Immunol. 20: 24-30. (Pubitemid 30210103)
34. + medullary thymic epithelial cells. Nat. Immunol. 8: 351-358.
35. Derbinski, J., J. Gabler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. Peltonen, J. Walter, and B. Kyewski. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202: 33-45. (Pubitemid 41002908)
36. Fazilleau, N., C. Delarasse, C. H. Sweenie, S. M. Anderton, S. Fillatreau, F. A. Lemonnier, D. Pham-Dinh, and J. M. Kanellopoulos. 2006. Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice. Eur. J. Immunol. 36: 533-543.
37. Wekerle, T., and M. Sykes. 2001. Mixed chimerism and transplantation tolerance. Annu. Rev. Med. 52: 353-370.
38. Tian, C., J. Bagley, N. Cretin, N. Seth, K. W. Wucherpfennig, and J. Iacomini. 2004. Prevention of type 1 diabetes by gene therapy. J. Clin. Invest. 114: 969-978. (Pubitemid 39578725)
39. + T cell repertoire. J. Clin. Invest. 116: 156-162.
40. Tian, C., J. Bagley, and J. Iacomini. 2006. Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells. Am. J. Transplant. 6: 2202-2207. (Pubitemid 44199556)
41. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
42. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
43. H17 cells. Nat. Med. 14: 337-342.
44. Keech, C. L., A. D. Farris, D. Beroukas, T. P. Gordon, and J. McCluskey. 2001. Cognate T cell help is sufficient to trigger anti-nuclear autoantibodies in naive mice. J. Immunol. 166: 5826-5834.
45. Chan, J., E. J. Ban, K. H. Chun, S. Wang, J. McQualter, C. Bernard, B-H. Toh, and F. Alderuccio. 2008. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Autoimmunity 41: 405-413. (Pubitemid 351891202)